P16 Expression in Squamous Cell Carcinomas of Cervix and Bladder

@article{CioffiLavina2010P16EI,
  title={P16 Expression in Squamous Cell Carcinomas of Cervix and Bladder},
  author={Maureen Cioffi-Lavina and Jennifer R. Chapman-Fredricks and Carmen R. Gomez-Fernandez and Parvin Ganjei‐Azar and Murigesan Manoharan and Merc{\'e} Jord{\'a}},
  journal={Applied Immunohistochemistry \& Molecular Morphology},
  year={2010},
  volume={18},
  pages={344-347}
}
Context/Objectivep16 is a widely used immunohistochemical marker in gynecologic pathology. Strong and diffuse cytoplasmic and nuclear expression of p16 in squamous cell carcinomas (SCC) of the female genital tract is strongly associated with high-risk human papilloma virus infection and neoplasms of cervical origin. However, p16 can be expressed in other neoplasms and in several normal human tissues. Occasionally, SCCs may involve both uterine cervix and urinary bladder. Accurate identification… Expand
IMMUNOHISTOCHEMICAL EXPRESSION OF P16 IN CERVICAL AND URINARY BLADDER SQUAMOUS CELL CARCINOMA
Background: p16 is a tumor suppressor protein important in regulating cell cycle. In bladder cancer, p16 mutations are widespread and tend to be more prevalent in low-grade superficial tumors than inExpand
Expression of P 16 Tumor Marker in Cervical Cancer among Sudanese Women
Background: Cervical cancer is one of the most common cancers affecting women worldwide. It is a malignant neoplasm arising from cell originating in the cervix uteri and it is the third most commonExpand
Prevalence of high-risk human papillomavirus in primary squamous cell carcinoma of urinary bladder.
TLDR
The study suggests that HPV infection does not play an etiologic role in the development of bladder cancer and should not be used as a diagnostic adjunct for these cases. Expand
High-risk human papillomavirus DNA detected in primary squamous cell carcinoma of urinary bladder.
TLDR
High-risk HPV DNA is detectable in a subset of primary bladder SCCs and there is a necessity for additional studies to investigate the role of HR-HPV in bladder carcinogenesis. Expand
Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection
TLDR
This is the first report of squamous tumors arising in the setting of concurrent neurogenic bladder and HPV infection, similar to that of other high-risk HPV-associated squamous carcinomas with a basaloid, poorly differentiated appearance and little to no keratin formation. Expand
Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions
TLDR
The combined detection of Ki-67 and P16 protein has a high application prospect as an auxiliary diagnosis of SCC and is positively correlated with the degree of cervical lesions. Expand
P16INK4A Immunohistochemistry as a Gold Standard for Cervical Cancer and Precursor Lesions Screening
TLDR
The molecular biomarker p16INK4a can be a good candidate for the early diagnosis and prognosis of cervical cancer in HPV-infected patients because of the increase in the expression level of p16ink4a in cancer and precancer tissues. Expand
Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature review.
TLDR
This study case demonstrates HPV infection with a low risk subtype (HPV 6/11) associated with an urothelial carcinoma with squamous differentiation and condylomatous features. Expand
Pathological possibilities and pitfalls in detecting aggressive bladder cancer
TLDR
Molecular-based detection techniques represent potentially attractive strategies for noninvasive detection of aggressive bladder cancer using urine as the specimen source, but are currently limited by their sensitivity and potential for false-positive results, and are unlikely to substitute cystoscopy. Expand
Urinary Bladder and Urachus
TLDR
This chapter addresses biopsies from the urinary bladder by profiling immunohistochemical stains that change their patterns of expression from that of normal urothelium, including both the cellular layers and cellular compartments in which markers are expressed. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 14 REFERENCES
p16 Expression in the Female Genital Tract and Its Value in Diagnosis
TLDR
In cervical squamous lesions, p16 is positive in most high-grade cervical intraepithelial neoplasia (CIN) and in some cases of low-grade CIN, usually those associated with high-risk HPV, whereas the more common non-HPV-associated neoplasms are largely negative or focally positive. Expand
Immunohistochemical Expression of p16(INK4A) in Normal Uterine Cervix, Nonneoplastic Epithelial Lesions, and Low-grade Squamous Intraepithelial Lesions
Objectives. In this study, the authors analyzed the immunoexpression of p16 in high-risk human papillomavirus DNA-negative normal and nonneoplastic cervical epithelia, in low-grade cervicalExpand
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.
TLDR
Data indicate that p16 is a technically simple immunohistological marker, applicable for routine pathological histology, and its prognostic value for survival is fully equivalent to HPV-DNA detection. Expand
Expression of p16, Rb, and p53 Proteins in Squamous Cell Carcinomas of the Anorectal Region Harboring Human Papillomavirus DNA
TLDR
Observations indicate that overexpression of p16 and loss of Rb nuclear staining are commonly associated with high-risk HPV infection, which may serve as useful surrogate biomarkers for identifying squamous cell carcinomas harboring HPV DNA. Expand
Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.
TLDR
The immunohistochemical localization of p16 in all human organs was analyzed and demonstrated that cellular p16 expression is highly selective, which may reflect a role of p 16 in cellular senescence. Expand
P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma.
TLDR
There is a significant correlation between loss of p16 expression and tumor progression in patients with minimally-invasive bladder cancer and immunohistochemical p16 staining may represent a useful tool of providing additional information on the clinical outcome of these patients. Expand
Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia.
TLDR
Findings indicate that p16(INK4a) is a specific marker for premalignant and malignant lesions of the squamous and endocervical mucosa and shows a generally inverse correlation with the expression of p16 (INK 4a) at the tissue level. Expand
The utility of p16(Ink4a) in discriminating between cervical intraepithelial neoplasia 1 and nonneoplastic equivocal lesions of the cervix.
TLDR
The data support the routine use of p16(Ink4a) immunohistochemical evaluation of cervical biopsy specimens for better discrimination of non-HPV-associated lesions from HPV-related lesions. Expand
Squamous Cell Carcinoma of the Bladder: A Clinicopathologic Analysis of 45 Cases
TLDR
In conclusion, squamous cell carcinoma often presents at an advanced stage; however, radical cystectomy with lymph node dissection appears to offer a significant benefit in survival in a subset of patients. Expand
p16INK4a Immunohistochemistry Improves Interobserver Agreement in the Diagnosis of Cervical Intraepithelial Neoplasia
It has been repeatedly shown that there is a substantial lack of interobserver reproducibility in the histologic diagnosis of cervical intraepithelial neoplasia (CIN), which might be improved by aExpand
...
1
2
...